Skip to main content
Subscribe
  • Sign Up Free
  • Login
  • Subscribe
  • News
    • Current News
    • Providers
    • Insurance
    • Government
    • Finance
    • Technology
    • Safety & Quality
    • Digital Health
    • Transformation
    • ESG
    • People
    • Regional News
    • Digital Edition (Web Version)
    • Patients
    • Operations
    • Care Delivery
    • Payment
    • Midwest
    • Northeast
    • South
    • West
  • Blogs
    • AI
    • Deals
    • Layoff Tracker
    • HIMSS 2023
  • Opinion
    • Breaking Bias
    • Commentaries
    • Letters
    • From the Editor
  • Events & Awards
    • Awards
    • Conferences
    • Galas
    • Virtual Briefings
    • Webinars
    • Nominate/Eligibility
    • 100 Most Influential People
    • 50 Most Influential Clinical Executives
    • Best Places to Work in Healthcare
    • Excellence in Governance
    • Health Care Hall of Fame
    • Healthcare Marketing Impact Awards
    • Top 25 Emerging Leaders
    • Top Innovators
    • Diversity in Healthcare
      • - Luminaries
      • - Top 25 Diversity Leaders
      • - Leaders to Watch
    • Women in Healthcare
      • - Luminaries
      • - Top 25 Women Leaders
      • - Women to Watch
    • Digital Health Transformation Summit
    • ESG: The Implementation Imperative Summit
    • Leadership Symposium
    • Social Determinants of Health Symposium
    • Women Leaders in Healthcare Conference
    • Best Places to Work Awards Gala
    • Health Care Hall of Fame Gala
    • Top 25 Diversity Leaders Gala
    • Top 25 Women Leaders Gala
    • - Hospital of the Future
    • - Value Based Care
    • - Hospital at Home
    • - Workplace of the Future
    • - AI and Digital Health
    • - Future of Staffing
    • - Hospital of the Future (Fall)
  • Multimedia
    • Podcast - Beyond the Byline
    • Sponsored Podcast - Healthcare Insider
    • Sponsored Video Series - One on One
    • Sponsored Video Series - Checking In with Dan Peres
  • Data & Insights
    • Data & Insights Home
    • Hospital Financials
    • Staffing & Compensation
    • Quality & Safety
    • Mergers & Acquisitions
    • Data Archive
    • Resource Guide: By the Numbers
    • Surveys
    • Data Points
  • Newsletters
  • MORE+
    • Contact Us
    • Advertise
    • Media Kit
    • Jobs
    • People on the Move
    • Reprints & Licensing
MENU
Breadcrumb
  1. Home
  2. Opinion
July 30, 2020 04:56 PM

Let science, not politics, rule on vaccine approval

Merrill Goozner
  • Tweet
  • Share
  • Share
  • Email
  • More
    Reprints Print
    merrill-goozner

    Merrill Goozner

    There are more unknowns than knowns as the first COVID-19 vaccine trials get underway. Science—not the hype propagated by manufacturers to boost their stock price—will determine the impact of any vaccine that wins Food and Drug Administration approval.

    Unless a COVID-19 vaccine is far more effective than previously approved respiratory disease vaccines, it will become just another tool in the public health toolbox for ending the pandemic. How much immunity it provides and how long it lasts may not be known for a year.

    That means the most likely scenario for next winter and spring, even with an approved vaccine, is that social distancing and limits on public activities—particularly for at-risk groups like seniors and people with chronic conditions—will remain a part of daily life.

    The nation’s experience with the annual influenza vaccine offers a cautionary tale on what to expect. Only 45% of adults got a flu shot during the 2018-19 season.

    The shots are modestly effective—about 50%. In a preliminary survey of the effectiveness of the 2019-20 influenza vaccine, the Centers for Disease Control and Prevention tested over 4,000 people who presented at hospitals and physicians offices with flu-like symptoms.

    Among the quarter of patients who tested positive for the flu, 37% had been vaccinated. Among those who didn’t test positive, 55% had been vaccinated. It reduced the incidence of the disease. It didn’t eliminate it.

    The FDA is using that very low bar for any new COVID-19 vaccine. If it’s just 50% effective, the new vaccine will not provide herd immunity, even if everyone gets their shots. In an interview in late June, Dr. Anthony Fauci, director of the National Institute of Allergy and Infectious Diseases, expressed hopes a COVID-19 vaccine would be 70% to 75% effective.

    But even that high number won’t stop the disease’s spread if only about half the population gets vaccinated. A vaccine that effective would still require well over 80% uptake before it could be considered the primary weapon for ending the pandemic.

    Here’s the good news. President Donald Trump has endorsed a vaccine and is promoting development through Operation Warp Speed. That’s very different from his months of equivocation on social distancing and wearing masks.

    Let’s hope it lasts. His political base is disproportionately represented in the anti-vaxxer crowd. A Gallup poll taken in January (before the pandemic) showed 13% of Republicans believe vaccines are more dangerous than the diseases they fight. That compares to just 7% of Democrats. 

    Those numbers are probably lower today given the enormous economic dislocation caused by the pandemic. But sentiment could reverse if Trump loses. Many of his supporters will undoubtedly glom on to anything they can to express opposition to a new administration. A new vaccine will be a likely target for conspiracy theorists.

    There’s an even greater threat before the election. The president, who’s badly trailing former Vice President Joe Biden in the polls, will be sorely tempted to order his political appointees at the FDA to override the agency’s system for scientifically determining safety and efficacy. They could authorize emergency use based on preliminary data without even holding an advisory committee meeting.

    That’s not what the public wants. Nearly two-thirds of registered voters in a new Morning Consult poll said they want the FDA to fully test a COVID-19 vaccine even if that means delaying its availability. Just 22% said the U.S. should make the vaccine available without completed clinical trials.

    If the FDA bows to political pressure, the threat to a successful vaccination campaign won’t come from the right. Millions of Americans will postpone getting the shots until they are assured the vaccine is actually safe and effective.

    Letter
    to the
    Editor

    Send us a letter

    Have an opinion about this story? Click here to submit a Letter to the Editor, and we may publish it in print.

    Recommended for You
    Duly HQ 800x534.png
    Duly Health & Care physicians group lays off workers
    Nurses_Doctors_Staffing_Shortage
    Rehabilitation hospitals hit hard by labor shortages: survey
    Most Popular
    1
    Centene to lay off 2,000 workers
    2
    How health systems are battling price-gouging allegations
    3
    Senate advances bill to temporarily aid hospitals, health centers
    4
    Elevance, Blue Cross Louisiana halt $2.5B proposed deal
    5
    Tower Health to sell urgent care centers, close others
    Sponsored Content
    Get Newsletters

    Sign up for enewsletters and alerts to receive breaking news and in-depth coverage of healthcare events and trends, as they happen, right to your inbox.

    Subscribe Today
    MH Magazine Cover

    MH magazine offers content that sheds light on healthcare leaders’ complex choices and touch points—from strategy, governance, leadership development and finance to operations, clinical care, and marketing.

    Subscribe
    Connect with Us
    • LinkedIn
    • Twitter
    • Facebook
    • RSS

    Our Mission

    Modern Healthcare empowers industry leaders to succeed by providing unbiased reporting of the news, insights, analysis and data.

    Contact Us

    (877) 812-1581

    Email us

     

    Resources
    • Contact Us
    • Help Center
    • Advertise with Us
    • Ad Choices
    • Sitemap
    Editorial Dept
    • Submission Guidelines
    • Code of Ethics
    • Awards
    • About Us
    Legal
    • Terms and Conditions
    • Privacy Policy
    • Privacy Request
    Modern Healthcare
    Copyright © 1996-2023. Crain Communications, Inc. All Rights Reserved.
    • News
      • Current News
      • Providers
      • Insurance
      • Government
      • Finance
      • Technology
      • Safety & Quality
      • Digital Health
      • Transformation
        • Patients
        • Operations
        • Care Delivery
        • Payment
      • ESG
      • People
      • Regional News
        • Midwest
        • Northeast
        • South
        • West
      • Digital Edition (Web Version)
    • Blogs
      • AI
      • Deals
      • Layoff Tracker
      • HIMSS 2023
    • Opinion
      • Breaking Bias
      • Commentaries
      • Letters
      • From the Editor
    • Events & Awards
      • Awards
        • Nominate/Eligibility
        • 100 Most Influential People
        • 50 Most Influential Clinical Executives
        • Best Places to Work in Healthcare
        • Excellence in Governance
        • Health Care Hall of Fame
        • Healthcare Marketing Impact Awards
        • Top 25 Emerging Leaders
        • Top Innovators
        • Diversity in Healthcare
          • - Luminaries
          • - Top 25 Diversity Leaders
          • - Leaders to Watch
        • Women in Healthcare
          • - Luminaries
          • - Top 25 Women Leaders
          • - Women to Watch
      • Conferences
        • Digital Health Transformation Summit
        • ESG: The Implementation Imperative Summit
        • Leadership Symposium
        • Social Determinants of Health Symposium
        • Women Leaders in Healthcare Conference
      • Galas
        • Best Places to Work Awards Gala
        • Health Care Hall of Fame Gala
        • Top 25 Diversity Leaders Gala
        • Top 25 Women Leaders Gala
      • Virtual Briefings
        • - Hospital of the Future
        • - Value Based Care
        • - Hospital at Home
        • - Workplace of the Future
        • - AI and Digital Health
        • - Future of Staffing
        • - Hospital of the Future (Fall)
      • Webinars
    • Multimedia
      • Podcast - Beyond the Byline
      • Sponsored Podcast - Healthcare Insider
      • Sponsored Video Series - One on One
      • Sponsored Video Series - Checking In with Dan Peres
    • Data & Insights
      • Data & Insights Home
      • Hospital Financials
      • Staffing & Compensation
      • Quality & Safety
      • Mergers & Acquisitions
      • Data Archive
      • Resource Guide: By the Numbers
      • Surveys
      • Data Points
    • Newsletters
    • MORE+
      • Contact Us
      • Advertise
      • Media Kit
      • Jobs
      • People on the Move
      • Reprints & Licensing